These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 31386689

  • 1. Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome.
    Grosse C, Soltermann A, Rechsteiner M, Grosse A.
    PLoS One; 2019; 14(8):e0220691. PubMed ID: 31386689
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.
    Grosse A, Grosse C, Rechsteiner M, Soltermann A.
    Diagn Pathol; 2019 Feb 11; 14(1):18. PubMed ID: 30744664
    [Abstract] [Full Text] [Related]

  • 3. Lung cancer in never smokers from the Princess Margaret Cancer Centre.
    Korpanty GJ, Kamel-Reid S, Pintilie M, Hwang DM, Zer A, Liu G, Leighl NB, Feld R, Siu LL, Bedard PL, Tsao MS, Shepherd FA.
    Oncotarget; 2018 Apr 27; 9(32):22559-22570. PubMed ID: 29854298
    [Abstract] [Full Text] [Related]

  • 4. The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
    Aisner DL, Sholl LM, Berry LD, Rossi MR, Chen H, Fujimoto J, Moreira AL, Ramalingam SS, Villaruz LC, Otterson GA, Haura E, Politi K, Glisson B, Cetnar J, Garon EB, Schiller J, Waqar SN, Sequist LV, Brahmer J, Shyr Y, Kugler K, Wistuba II, Johnson BE, Minna JD, Kris MG, Bunn PA, Kwiatkowski DJ, LCMC2 investigators.
    Clin Cancer Res; 2018 Mar 01; 24(5):1038-1047. PubMed ID: 29217530
    [Abstract] [Full Text] [Related]

  • 5. Analysis of multigene detection in patients with advanced lung adenocarcinoma using cytological specimens.
    Ma Y, Du Y, Wang R, Ji X, Wu J, Liu Y, Guo X, Zhang Y.
    Pathol Res Pract; 2020 Aug 01; 216(8):153036. PubMed ID: 32703499
    [Abstract] [Full Text] [Related]

  • 6. Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
    Mack PC, Klein MI, Ayers KL, Zhou X, Guin S, Fink M, Rossi M, Ai-Kateb H, O'Connell T, Hantash FM, Oh WK, Newman S, Schadt EE, Chen R, Hirsch FR.
    Oncologist; 2022 Jun 08; 27(6):476-486. PubMed ID: 35298662
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.
    Luo W, Tian P, Wang Y, Xu H, Chen L, Tang C, Shu Y, Zhang S, Wang Z, Zhang J, Zhang L, Jiang L, Liu L, Che G, Guo C, Zhang H, Wang J, Li W.
    Int J Cancer; 2018 Oct 01; 143(7):1696-1705. PubMed ID: 29667179
    [Abstract] [Full Text] [Related]

  • 10. Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR.
    Ha SY, Choi SJ, Cho JH, Choi HJ, Lee J, Jung K, Irwin D, Liu X, Lira ME, Mao M, Kim HK, Choi YS, Shim YM, Park WY, Choi YL, Kim J.
    Oncotarget; 2015 Mar 10; 6(7):5465-74. PubMed ID: 25760072
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers.
    Garrido J, Bernal Y, González E, Blanco A, Sepúlveda-Hermosilla G, Freire M, Oróstica K, Rivas S, Marcelain K, Owen G, Ibañez C, Corvalan A, Garrido M, Assar R, Lizana R, Cáceres-Molina J, Ampuero D, Ramos L, Pérez P, Aren O, Chernilo S, Fernández C, Spencer ML, Aguila JF, Dossetto GB, Olea MA, Rasse G, Sánchez C, de Amorim MG, Bartelli TF, Nunes DN, Dias-Neto E, Freitas HC, Armisén R.
    BMC Cancer; 2024 Aug 03; 24(1):951. PubMed ID: 39097719
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Profiling of Oncogenic Driver Events in Lung Adenocarcinoma Revealed MET Mutation as Independent Prognostic Factor.
    Yeung SF, Tong JHM, Law PPW, Chung LY, Lung RWM, Tong CYK, Chow C, Chan AWH, Wan IYP, Mok TSK, To KF.
    J Thorac Oncol; 2015 Sep 03; 10(9):1292-1300. PubMed ID: 26098749
    [Abstract] [Full Text] [Related]

  • 19. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.
    Tanaka K, Hida T, Oya Y, Yoshida T, Shimizu J, Mizuno T, Kuroda H, Sakakura N, Yoshimura K, Horio Y, Sakao Y, Yatabe Y.
    Cancer; 2017 May 15; 123(10):1731-1740. PubMed ID: 28177518
    [Abstract] [Full Text] [Related]

  • 20. Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.
    Wu SG, Liu YN, Yu CJ, Yang JC, Shih JY.
    Genes Chromosomes Cancer; 2018 Oct 15; 57(10):513-521. PubMed ID: 30107055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.